These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. Van Rompay KK; Trott KA; Jayashankar K; Geng Y; LaBranche CC; Johnson JA; Landucci G; Lipscomb J; Tarara RP; Canfield DR; Heneine W; Forthal DN; Montefiori D; Abel K Retrovirology; 2012 Jul; 9():57. PubMed ID: 22805180 [TBL] [Abstract][Full Text] [Related]
15. Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2. Mattapallil JJ; Smit-McBride Z; Dailey P; Dandekar S J Virol; 1999 Aug; 73(8):6661-9. PubMed ID: 10400763 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA. Van Rompay KK; Miller MD; Marthas ML; Margot NA; Dailey PJ; Canfield DR; Tarara RP; Cherrington JM; Aguirre NL; Bischofberger N; Pedersen NC J Virol; 2000 Feb; 74(4):1767-74. PubMed ID: 10644348 [TBL] [Abstract][Full Text] [Related]
17. Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection. Van Rompay KK; Johnson JA; Blackwood EJ; Singh RP; Lipscomb J; Matthews TB; Marthas ML; Pedersen NC; Bischofberger N; Heneine W; North TW Retrovirology; 2007 Apr; 4():25. PubMed ID: 17417971 [TBL] [Abstract][Full Text] [Related]
18. Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG. Shen Y; Shen L; Sehgal P; Zhou D; Simon M; Miller M; Enimi EA; Henckler B; Chalifoux L; Sehgal N; Gastron M; Letvin NL; Chen ZW J Virol; 2001 Sep; 75(18):8690-6. PubMed ID: 11507214 [TBL] [Abstract][Full Text] [Related]
19. Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection. Tsai CC; Emau P; Sun JC; Beck TW; Tran CA; Follis KE; Bischofberger N; Morton WR J Med Primatol; 2000 Aug; 29(3-4):248-58. PubMed ID: 11085587 [TBL] [Abstract][Full Text] [Related]
20. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection. Mori K; Yasutomi Y; Sawada S; Villinger F; Sugama K; Rosenwith B; Heeney JL; Uberla K; Yamazaki S; Ansari AA; Rübsamen-Waigmann H J Virol; 2000 Jul; 74(13):5747-53. PubMed ID: 10846052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]